Cliff Asness’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.2M Sell
692,541
-282,356
-29% -$18.5M 0.03% 703
2026
Q1
$7.71M Buy
974,897
+566,426
+139% +$9.16M ﹤0.01% 1480
2025
Q4
$7.03M Buy
408,471
+380,234
+1,347% +$7.37M ﹤0.01% 1380
2025
Q3
$727K Buy
28,237
+152
+0.5% +$5.74K ﹤0.01% 2617
2025
Q2
$1.61M Buy
28,085
+8,027
+40% +$644K ﹤0.01% 1914
2025
Q1
$2.17M Buy
20,058
+14,215
+243% +$1.24M ﹤0.01% 1565
2024
Q4
$278K Buy
5,843
+3,087
+112% +$187K ﹤0.01% 2526
2024
Q3
$261K Sell
2,756
-51,502
-95% -$6.65M ﹤0.01% 2458
2024
Q2
$8.87M Buy
54,258
+52,680
+3,338% +$7.5M 0.01% 792
2024
Q1
$232K Buy
+1,578
New +$263K ﹤0.01% 2215

Other funds holding AGL

Cliff Asness's AGL Position: Q2 2026 in Review

Cliff Asness reduced its Agilon Health (AGL) stake by 29% in Q2 2026, selling an estimated $18.5M and leaving 692,541 shares worth $74.2M. The position accounts for 0.03% of the portfolio, ranked #703.

Cliff Asness first reported a position in AGL in Q1 2024 and has held it in 10 quarters since. 180 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Cliff Asness held 692,541 shares of Agilon Health worth $74.2M as of Q2 2026.
  • Cliff Asness sold 282,356 Agilon Health shares in Q2 2026, an estimated $18.5M.
  • Agilon Health made up 0.03% of Cliff Asness's portfolio in Q2 2026, its #703 holding.
  • Cliff Asness first reported a position in Agilon Health in Q1 2024 and has held it in 10 quarters since.
  • 180 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.